Promoted for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Dr. Martens stock in Canada
Own Dr. Martens shares in just a few minutes.
Dr. Martens plc is a footwear & accessories business based in the UK. Dr. Martens shares (DOCS.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. Dr. Martens employs 1,606 staff and has a trailing 12-month revenue of around £721.7 million.
How to buy shares in Dr. Martens
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: DOCS in this case.
- Research Dr. Martens shares. The platform should provide the latest information available.
- Buy your Dr. Martens shares. It's that simple.
Promoted for
Advanced Traders
Promoted for
User Experience
Promoted for
Trading ETFs
Dr. Martens share price
Use our graph to track the performance of DOCS stocks over time.Dr. Martens shares at a glance
Information last updated 2021-02-23.
| Latest market close | N/Ap |
|---|---|
| 52-week range | 414.3p - 521.6p |
| 50-day moving average | 486.0471p |
| 200-day moving average | 486.0471p |
| PE ratio | 0.6484 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | 748p |
Compare online trading platforms
Is it a good time to buy Dr. Martens stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Is Dr. Martens under- or over-valued?
Valuing Dr. Martens stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Dr. Martens's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Dr. Martens's P/E ratio
Dr. Martens's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, Dr. Martens shares trade at around 1x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Dr. Martens's EBITDA
Dr. Martens's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £184.5 million.
The EBITDA is a measure of a Dr. Martens's overall financial performance and is widely used to measure a its profitability.
Dr. Martens financials
| Revenue TTM | £721.7 million |
|---|---|
| Operating margin TTM | 23.89% |
| Gross profit TTM | £390.6 million |
| Return on assets TTM | 0% |
| Return on equity TTM | 0% |
| Profit margin | 12.06% |
| Book value | 7.05p |
| Market capitalisation | £4.8 billion |
TTM: trailing 12 months
Dr. Martens share dividends
We're not expecting Dr. Martens to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Dr. Martens overview
Dr. Martens Limited engages in the manufacture and sale of footwear in the United Kingdom and internationally. Its product segments include originals, fusion, kids and casual, and a complementary range of accessories. The company offers its products under Dr. Martens brand name. It operates Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens Limited was founded in 1960 and is based in London, the United Kingdom.
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to buy Dr. Martens stock in Canada
Steps to owning and managing Agora stocks, with 24-hour and historical pricing before you buy.
-
How to buy Dr. Martens stock in Canada
Steps to owning and managing Aethlon Medical stocks, with 24-hour and historical pricing before you buy.
-
How to buy Dr. Martens stock in Canada
Steps to owning and managing Advanced Drainage Systems stocks, with 24-hour and historical pricing before you buy.
-
How to buy Dr. Martens stock in Canada
Steps to owning and managing ADT stocks, with 24-hour and historical pricing before you buy.
-
How to buy Dr. Martens stock in Canada
Steps to owning and managing Adaptive Biotechnologies Corporation stocks, with 24-hour and historical pricing before you buy.
-
How to buy Dr. Martens stock in Canada
Steps to owning and managing ABB stocks, with 24-hour and historical pricing before you buy.
-
How to buy Dr. Martens stock in Canada
Steps to owning and managing Xenetic Biosciences stocks, with 24-hour and historical pricing before you buy.
-
How to buy Dr. Martens stock in Canada
Steps to owning and managing Vivint Smart Home stocks, with 24-hour and historical pricing before you buy.
-
How to buy Dr. Martens stock in Canada
Steps to owning and managing VistaGen Therapeutics stocks, with 24-hour and historical pricing before you buy.
-
How to buy Dr. Martens stock in Canada
Steps to owning and managing Varian Medical Systems stocks, with 24-hour and historical pricing before you buy.